Loading stock data…
CVS
$92.22+1.67 (+1.84%)
Market ClosedLast close May 11
CVS Health Corporation provides health solutions in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
CVS Health Corporation in the Healthcare sector is trading at $92.22. The stock is currently near its 52-week high of $92.77, remaining 22.7% above its 200-day moving average. Technical signals show overbought RSI of 80 and bullish MACD crossover, explaining why CVS maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 80) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$92.22
Potential Downside
65.8%
Whystock Fair Value$31.57
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus26 analysts
Mean target$100.23+8.7%
Range$79.00 – $140.00
Fundamentals
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$99.93B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
56.09
Beta
Defensive asset. Lower volatility than the S&P 500.
0.51
Div Yield
Strong income play. Yield provides a meaningful total return floor.
348.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.02%
Volume
Today's trading volume
11.04M
Recent News
CVS Health Expands Community Care Push As Valuation Gap Draws Attention
CVS Health (NYSE:CVS) expanded its MinuteClinic partnership with Hartford HealthCare to offer adult primary care at all Connecticut locations. Aetna Better Health, a CVS Health business, is providing funding to community health initiatives in Missouri focused on underserved populations. For investors tracking NYSE:CVS, these updates sit alongside a share price of $92.22 and strong recent momentum, with the stock up 12.4% over the past week and 16.2% over the past month. Returns of 15.1%...
CVS Health Stock Breaks Out as Technical Indicators Turn Bright Green
CVS Health (CVS) shares have reclaimed their 50-day moving average and are challenging their all-time high around $95 following an eight-month consolidation period. The stock currently maintains a 72% “Buy” technical opinion from Barchart, signaling strong alignment across short, medium, and long-term timeframes. This level for that indicator has been...
A Look At CVS Health (CVS) Valuation After Earnings Beat And Raised 2026 Guidance
CVS Health (CVS) is back in focus after first quarter 2026 results and raised full year guidance, with management highlighting broad based strength across Aetna, Health Services, and Pharmacy & Consumer Wellness. See our latest analysis for CVS Health. After the earnings beat and guidance raise, the share price has climbed to US$90.55, with a 1 month share price return of 14.14% and a 1 year total shareholder return of 44.83%. This suggests momentum has picked up recently compared with longer...
Morgan Stanley drops one big takeaway in CVS stock earnings beat
Healthcare stocks have had a rough stretch. Rising medical costs, Medicaid pressure, and persistent skepticism about managed care margins have kept investors on edge all year. Walking into a CVS Health earnings report in that environment felt like bracing for bad news. The bad news, however, didn't ...
CVS Health Q1 Earnings Call Highlights
CVS Health (NYSE:CVS) raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations. On the company’s first-quarter earnings call, David Joyn